0001813747-20-000001.txt : 20200618
0001813747-20-000001.hdr.sgml : 20200618
20200618152842
ACCESSION NUMBER: 0001813747-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
EFFECTIVENESS DATE: 20200618
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solas BioVentures Fund II, LP
CENTRAL INDEX KEY: 0001813747
IRS NUMBER: 850627769
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-369247
FILM NUMBER: 20972206
BUSINESS ADDRESS:
STREET 1: 835 GEORGIA AVENUE
STREET 2: SUITE 800
CITY: CHATTANOOGA
STATE: TN
ZIP: 37402
BUSINESS PHONE: (423) 648-7894
MAIL ADDRESS:
STREET 1: 835 GEORGIA AVENUE
STREET 2: SUITE 800
CITY: CHATTANOOGA
STATE: TN
ZIP: 37402
D
1
primary_doc.xml
X0708
D
LIVE
0001813747
Solas BioVentures Fund II, LP
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
(423) 648-7894
DELAWARE
None
None
Limited Partnership
true
2020
Mark
N/A
Hackett
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
Executive Officer
Promoter
Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer
Michael
N/A
Hoey
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
Executive Officer
Promoter
Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer
Charles
David
Adair
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
Executive Officer
Promoter
Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer
N/A
N/A
Solas Partners II, LLC
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
Promoter
General Partner of Issuer
N/A
N/A
Solas BioVentures Management, LLC
835 GEORGIA AVENUE
SUITE 800
CHATTANOOGA
TN
TENNESSEE
37402
Promoter
Investment Manager of Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
false
2020-06-05
false
true
false
500000
Indefinite
5150000
Indefinite
false
13
0
true
0
true
50000
true
The Issuer's organizational expenses will be reimbursed by the Issuer to the General Partner and/or Investment Manager. The Investment Manager will receive an annual management fee from the Issuer as described in the Issuer's offering documents
false
Solas BioVentures Fund II, LP
Mark Hackett
Mark Hackett
Manager
2020-06-18